Smart Syringes Market by syringes Type (Auto disable, Active safety, Passive safety), Application (Drug delivery, Vaccination, Blood specimen collection) and End User, (Hospitals and HMOs, Diabetic patients, Family practices, Psychiatrics) - Global Opportunity Analysis and Industry Forecast, 2014 - 2020

Smart syringes can be defined as medical devices that are engineered with safety mechanisms to prevent the reuse of syringes and regulates unsafe injection practices. Smart syringes are designed with features to protect the person being injected from needle stick injuries, blood-borne diseases such as hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV) and resulting deadly infections. They cater to a wide range of applications that include vaccination, drug delivery, and blood specimen collection. Different types of smart syringes including auto disable (AD) syringes, passive safety syringes and active safety syringes are used depending on the nature of application. Active safety syringes are the most common type of smart syringes used across all healthcare sectors, whereas, auto disable (AD) syringes are the most popular syringes used for vaccination purposes.

The world smart syringes market was evaluated at $4.8 billion in 2015, and is estimated to garner $7.6 billion by 2020, registering a CAGR of 9.6% over the forecast period. The world smart syringes market is driven by increasing count of needle stick injuries, high prevalence of blood-borne transmission such as Hepatitis B, C, HIV through improper injection practices, growing adoption of safety syringes and technological advancements. In addition, mandatory recommendation by WHO to switch to smart syringes ensuring safe injection practices is the major factor boosting the market growth. However, the high cost associated with smart syringes especially passive safety syringes, low awareness in developing economies and alternative drug delivery methods are likely to impede the market growth. The world smart syringes market volume is projected to reach 15.8 billion units by 2020 and is projected to grow at a CAGR of 8.2 during the forecast period.

The world smart syringes market is segmented based on types, applications, end users and geography. The type segment is further categorized into auto disable (AD) syringes, active safety syringes and passive safety syringes. Active safety syringes accounts for the highest revenue in 2015, owing to established market position. Furthermore, auto disable (AD) syringes are especially used for vaccination purposes and are designed specifically for single use, embedded with an internal mechanism that blocks the barrel once used, thereby preventing its further usage.

The world smart syringes market by application is categorized into drug delivery, vaccination, and blood specimen collection. Among these, the drug delivery segment generated the highest revenue in 2015. Several advantages associated with syringes such as better bioavailability of intravenous drugs, shorter onset time, accurate titration of the dosage, among others have boosted the market growth. Based on end user, the smart syringes market is categorized into hospitals, diabetic patients, family practices, and psychiatrics among others. Based on geography, the market is segmented into North America, Europe, Asia-Pacific, and LAMEA. North America would continue to dominate the market until 2020, on account of higher adoption of smart syringes, high awareness among the consumers about smart syringes and high healthcare expenditure across the region.

Competitive Intelligence on prominent manufacturers of smart syringes provide key insights in terms of strategies implemented to gain significant share in the smart syringes market. Becton, Dickinson & Company are the leading player that provides a wide range of smart syringes across all healthcare sectors worldwide. Few of the smart syringes provided by these company include BD Eclipse and BD SafetyGlide syringes (uses active system), BD AutoShield Duo Pen Needle (passive mechanism), and BD Soloshot IX Auto-Disable 0.5 mL syringe among others. The key companies operating in the world smart syringes market include Becton, Dickinson and Company, Medtronic (Covidien), Terumo Medical Corporation, B. Braun Melsungen AG, Baxter International, Smiths Group plc, Unilife Corporation, Revolutions Medical Corporation and Retractable Technologies, Inc., among others.

KEY BENEFITS:

    This report provides an extensive analysis of the current and emerging market trends and dynamics in the world smart syringes market.

    The smart syringes market scenario has been comprehensively analyzed on the basis of key geographical regions.

    The report provides a detailed analysis of the current market and estimations from 2014 to 2020, which would enable the stakeholders to capitalize on the prevailing market opportunities.

    A comprehensive analysis of the market scenario in terms of applications, types, end users, and geography helps in identifying the prevailing opportunities in the world smart syringes market.

    The key market players operating in the market have been profiled in the report, and their strategies have been thoroughly analyzed to understand the competitive outlook of the market.

SMART SYRINGES MARKET KEY SEGMENTS:

Market By Type

    Auto disable syringes

    Active safety syringes

    Passive safety syringes

Market By Application

    Drug delivery

    Vaccination

    Blood specimen collection

Market By End User

    Hospitals and HMOs

    Diabetic patients

    Family practices (Physicians)

    Psychiatrics

    Others

Market By Geography

    North America

    Europe

    Asia-Pacific

    LAMEA

CHAPTER 1 INTRODUCTION

1.1 Report description

1.2 Key benefits

1.3 Key market segments

1.4 Research methodology

1.4.1 Secondary research

1.4.2 Primary research

1.4.3 Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1 CXO perspective

2.2 Market beyond what to expect by 2025 ($Million)

2.2.1 Moderate growth scenario

2.2.2 Rapid growth scenario

2.2.3 Diminishing growth scenario

CHAPTER 3 MARKET OVERVIEW

3.1 Market definition and scope

3.2 Key findings

3.2.1 Top investment pockets

3.2.2 Top winning strategies

3.3 Porters five forces analysis

3.3.1 Low bargaining power of supplier

3.3.2 High bargaining power of buyer

3.3.3 Fierce competition among manufacturers

3.3.4 Moderate threat of substitutes

3.3.5 High threat of new entrants

3.4 Value chain analysis

3.5 Market share analysis, (2014)

3.6 Government regulations

3.7 Market dynamics

3.7.1 Drivers

3.7.2 Restraints

3.7.3 Opportunities

CHAPTER 4 WORLD SMART SYRINGES MARKET BY TYPE, 2014-2020

4.1 Overview

4.1.1 Key market trends

4.1.2 Key growth factors and opportunities

4.1.3 Market size and forecast

4.2 Auto-disable syringes

4.2.1 Key market trends

4.2.2 Key growth factors and opportunities

4.2.3 Market size and forecast

4.3 Active safety syringes

4.3.1 Key market trends

4.3.2 Key growth factors and opportunities

4.3.3 Market size and forecast

4.4 Passive safety syringes

4.4.1 Key market trends

4.4.2 Key growth factors and opportunities

4.4.3 Market size and forecast

CHAPTER 5 WORLD SMART SYRINGES MARKET BY APPLICATION, 2014-2020

5.1 Overview

5.1.1 Market size and forecast

5.2 Drug delivery

5.2.1 Market size and forecast

5.3 Vaccination

5.3.1 Market size and forecast

5.4 Blood Specimen Collection

5.4.1 Market size and forecast

CHAPTER 6 WORLD SMART SYRINGES MARKET BY END USERS, 2014-2020

6.1 Overview

6.1.1 Market size and forecast

6.2 Hospitals and HMOs

6.2.1 Market size and forecast

6.3 Diabetic patients

6.3.1 Market size and forecast

6.4 Family practices (Physicians)

6.4.1 Market size and forecast

6.5 Psychiatrics

6.5.1 Market size and forecast

6.6 Others

6.6.1 Market size and forecast

CHAPTER 7 WORLD SMART SYRINGES MARKET BY GEOGRAPHY, 2014-2020

7.1 Overview

7.1.1 Market size and forecast

7.2 North America

7.2.1 Key market trends

7.2.2 Key growth factors and opportunities

7.2.3 Market size and forecast

7.3 Europe

7.3.1 Key market trends

7.3.2 Key growth factors and opportunities

7.3.3 Market size and forecast

7.4 Asia Pacific

7.4.1 Key market trends

7.4.2 Key growth factors and opportunities

7.4.1 Market size and forecast

7.5 LAMEA

7.5.1 Key market trends

7.5.2 Key growth factors and opportunities

7.5.3 Market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1 Becton, Dickinson and Co.

8.1.1 Company overview

8.1.2 Company snapshot

8.1.3 Business performance

8.1.4 Key strategies and recent developments

8.1.5 SWOT analysis

8.2 Medtronic Plc (Covidien)

8.2.1 Company overview

8.2.2 Company snapshot

8.2.3 Business performance

8.2.4 Key strategies and developments

8.2.5 SWOT analysis

8.3 Terumo Medical Corporation

8.3.1 Company overview

8.3.2 Company snapshot

8.3.3 Business performance

8.3.4 SWOT analysis

8.4 B. Braun Melsungen AG

8.4.1 Company overview

8.4.2 Company snapshot

8.4.3 Business performance

8.4.4SWOT analysis

8.5 Baxter International

8.5.1 Company overview

8.5.2 Company snapshot

8.5.3 Business performance

8.5.4 Key strategies and development

8.5.5 SWOT analysis

8.6 Smiths Group plc

8.6.1 Company overview

8.6.2 Company snapshot

8.6.3 Business performance

8.6.4 Key strategies and development

8.6.5 SWOT analysis

8.7 Unilife Corporation

8.7.1 Company overview

8.7.2 Company snapshot

8.7.3 Business performance

8.7.4 Key strategies and development

8.7.5 SWOT analysis

8.8 Revolutions Medical Corporation

8.8.1 Company overview

8.8.2 Company snapshot

8.8.3 Business performance

8.8.4 Key strategies and development

8.8.5 SWOT analysis

8.9 Retractable Technologies, Inc.

8.9.1 Company overview

8.9.2 Company snapshot

8.9.3 Business performance

8.9.4 SWOT analysi

TABLE 1 WORLD SMART SYRINGES MARKET, MODERATE GROWTH SCENARIO, 2020-2025($MILLION)

TABLE 2 WORLD SMART SYRINGES MARKET, RAPID GROWTH SCENARIO, 2020-2025($MILLION)

TABLE 3 WORLD SMART SYRINGES MARKET, DIMINISHING GROWTH SCENARIO, 2020-2025($MILLION)

TABLE 4 WORLD SMART SYRINGES MARKET REVENUE, BY TYPE, 2014-2020 ($MILLION)

TABLE 5 WORLD SMART SYRINGES MARKET VOLUME, BY TYPE, 2014-2020

TABLE 6 WORLD SMART SYRINGES MARKET REVENUE, BY GEOGRAPHY, 2014-2020 ($MILLION)

TABLE 7 WORLD SMART SYRINGES MARKET VOLUME, BY GEOGRAPHY, 2014-2020

TABLE 8 WORLD AUTO DISABLE SYRINGES MARKET REVENUE, BY GEOGRAPHY, 2014-2020 ($MILLION)

TABLE 9 WORLD AUTO DISABLE SYRINGES MARKET VOLUME, BY GEOGRAPHY, 2014-2020

TABLE 10 WORLD ACTIVE SYRINGES MARKET REVENUE, BY GEOGRAPHY, 2014-2020 ($MILLION)

TABLE 11 WORLD ACTIVE SYRINGES MARKET VOLUME, BY GEOGRAPHY, 2014-2020

TABLE 12 WORLD PASSIVE SYRINGES MARKET VOLUME, BY GEOGRAPHY, 2014-2020 ($MILLION)

TABLE 13 WORLD PASSIVE SYRINGES MARKET VOLUME, BY GEOGRAPHY, 2014-2020

TABLE 14 WORLD SMART SYRINGES MARKET REVENUE, BY APPLICATION, 2014-2020 ($MILLION)

TABLE 15 WORLD SMART SYRINGES MARKET VOLUME, BY APPLICATION, 2014-2020

TABLE 16 WORLD SMART SYRINGES APPLICATION MARKET REVENUE, BY GEOGRAPHY, 2014-2020 ($MILLION)

TABLE 17 WORLD SMART SYRINGES APPLICATION MARKET VOLUME, BY GEOGRAPHY, 2014-2020 ($MILLION)

TABLE 18 WORLD SMART SYRINGES CURATIVE PURPOSES MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)

TABLE 19 WORLD SMART SYRINGES DRUG DELIVERY MARKET VOLUME, BY GEOGRAPHY, 2014-2020,

TABLE 20 WORLD SMART SYRINGES VACCINATION MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)

TABLE 21 WORLD SMART SYRINGES VACCINATION MARKET VOLUME, BY GEOGRAPHY, 2014-2020

TABLE 22 WORLD SMART SYRINGES VACCINATION MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)

TABLE 23 WORLD SMART SYRINGES VACCINATION MARKET VOLUME, BY GEOGRAPHY, 2014-2020

TABLE 24 WORLD SMART SYRINGES MARKET REVENUE, BY END USER, 2014-2020, ($MILLION)

TABLE 25 WORLD SMART SYRINGES END USER MARKET VOLUME, BY GEOGRAPHY, 2014-2020

TABLE 26 WORLD SMART SYRINGES END USER MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)

TABLE 27 WORLD SMART SYRINGES END USER MARKET VOLUME, BY GEOGRAPHY, 2014-2020

TABLE 28 WORLD SMART SYRINGES HOSPITALS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)

TABLE 29 WORLD SMART SYRINGES HOSPITALS MARKET VOLUME, BY GEOGRAPHY, 2014-2020, ($MILLION)

TABLE 30 WORLD SMART SYRINGES DIABETIC PATIENTS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)

TABLE 31 WORLD SMART SYRINGES DIABETIC PATIENTS MARKET VOLUME, BY GEOGRAPHY, 2014-2020

TABLE 32 WORLD SMART SYRINGES FAMILY PRACTICES MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)

TABLE 33 WORLD SMART SYRINGES DIABETIC PATIENTS MARKET VOLUME, BY GEOGRAPHY, 2014-2020

TABLE 34 WORLD SMART SYRINGES PSYCHIATRICS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)

TABLE 35 WORLD SMART SYRINGES PSYCHIATRICS MARKET VOLUME, BY GEOGRAPHY, 2014-2020

TABLE 36 WORLD SMART SYRINGES OTHERS MARKET REVENUE, BY GEOGRAPHY, 2014-2020, ($MILLION)

TABLE 37 WORLD SMART SYRINGES OTHERS MARKET VOLUME, BY GEOGRAPHY, 2014-2020

TABLE 38 WORLD SMART SYRINGES APPLICATION MARKET REVENUE, BY GEOGRAPHY, 2014-2020 ($MILLION)

TABLE 39 WORLD SMART SYRINGES APPLICATION MARKET VOLUME, BY GEOGRAPHY, 2014-2020 ($MILLION)

TABLE 40 NORTH AMERICA SMART SYRINGES MARKET REVENUE, BY APPLICATION, 2014-2020 ($MILLION)

TABLE 41 NORTH AMERICA SMART SYRINGES MARKET VOLUME, BY APPLICATION, 2014-2020

TABLE 42 EUROPE SMART SYRINGES MARKET REVENUE, BY APPLICATION, 2014-2020, ($MILLION)

TABLE 43 EUROPE SMART SYRINGES MARKET VOLUME, BY APPLICATION, 2014-2020

TABLE 44 ASIA PACIFIC SMART SYRINGES MARKET REVENUE, BY APPLICATION, 2014-2020, ($MILLION)

TABLE 45 ASIA PACIFIC SMART SYRINGES MARKET VOLUME, BY APPLICATION, 2014-2020

TABLE 46 LAMEA SMART SYRINGES MARKET REVENUE, BY APPLICATION, 2014-2020, ($MILLION)

TABLE 47 LAMEA SMART SYRINGES MARKET VOLUME, BY APPLICATION, 2014-2020

TABLE 48 BECTON DICKINSON AND COMPANY SNAPSHOT

TABLE 49 COMPANY SNAPSHOT OF MEDTRONIC, INC.

TABLE 50 COMPANY SNAPSHOT OF TERUMO MEDICAL CORPORATION

TABLE 51 COMPANY SNAPSHOT OF B. BRAUN MELSUNGEN AG

TABLE 52 COMPANY SNAPSHOT OF BAXTER INTERNATIONAL

TABLE 53 COMPANY SNAPSHOT OF SMITHS GROUP PLC

TABLE 54 COMPANY SNAPSHOT OF UNIFIFE CORPORATION

TABLE 55 COMPANY SNAPSHOT OF REVOLUTIONS MEDICAL CORPORATION

TABLE 56 COMPANY SNAPSHOT OF RETRACTABLE TECHNOLOGIES, INC. FIG. 1 IMPACT ANALYSIS OF MODERATE GROWTH SCENARIO (2020-2025)

FIG. 2 IMPACT ANALYSIS OF RAPID GROWTH SCENARIO (2020-2025)

FIG. 3 IMPACT ANALYSIS OF DIMINISHING GROWTH SCENARIO (2020-2025)

FIG. 4 TOP INVESTMENT POCKETS IN WORLD REUSABLE INDUSTRIAL GLOVES MARKET, 20142020

FIG. 5 TOP WINNING STRATEGIES OF GLOBAL SMART SYRINGES MARKET (2013-2015)

FIG. 6 TOP WINNING STRATEGIES BY TYPE (2013-2015)

FIG. 7 AGREEMENT STRATEGY BY TYPE (2011-2015)

FIG. 8 PORTERS FIVE FORCES ANALYSIS OF WORLD SMART SYRINGES MARKET

FIG. 9 VALUE CHAIN ANALYSIS

FIG. 10 MARKET SHARE ANALYSIS OF WORLD SMART SYRINGES MARKET, 2014 ($MILLION)

FIG. 11 FREQUENCY (%) OF NEEDLE STICK INJURIES ACROSS DIFFERENT PROFESSION

FIG. 12 BECTON DICKINSON AND COMPANY REVENUE (2012-2014)

FIG. 13 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY BY SEGMENT (2014)

FIG. 14 KEY FINANCIALS OF BECTON DICKINSON AND COMPANY BY GEOGRAPHY (2014)

FIG. 15 SWOT ANALYSIS OF BECTON DICKINSON AND COMPANY

FIG. 16 KEY FINANCIALS OF MEDTRONIC, INC. BY OPERATING SEGMENT (2014)

FIG. 17 KEY FINANCIALS OF MEDTRONIC, INC. BY GEOGRAPHY (2014)

FIG. 18 SWOT ANALYSIS OF MEDTRONIC, INC.

FIG. 19 TERUMO MEDICAL CORPORATION FINANCIAL REVENUES BY BUSINESS SEGMENT (2014)

FIG. 20 TERUMO MEDICAL CORPORATION FINANCIAL REVENUES BY GEOGRAPHY (2014)

FIG. 21 SWOT ANALYSIS OF TERUMO MEDICAL CORPORATION

FIG. 22 B. BRAUN FINANCIAL REVENUES BY BUSINESS SEGMENT, 2014

FIG. 23 B. BRAUN FINANCIAL REVENUES BY GEOGRAPHY, 2014

FIG. 24 SWOT ANALYSIS OF B. BRAUN MELSUNGEN AG

FIG. 25 BAXTER INTERNATIONAL REVENUE BY BUSINESS SEGMENTS (2013)

FIG. 26 BAXTER INTERNATIONAL REVENUE BY GEOGRAPHY (2013)

FIG. 27 SWOT ANALYSIS

FIG. 28 SMITHS GROUP FINANCIAL REVENUES BY BUSINESS SEGMENT (2014)

FIG. 29 SMITHS GROUP FINANCIAL REVENUES BY GEOGRAPHY (2014)

FIG. 30 SWOT ANALYSIS OF SMITHS GROUP PLC

FIG. 31 KEY FINANCIALS OF UNILIFE CORPORATION ($MILLION)

FIG. 32 UNILIFE CORPORATION GEOGRAPHIC FINANCIAL REVENUES BY BUSINESS SEGMENT (2015)

FIG. 33 SWOT ANALYSIS OF UNILIFE CORPORATION

FIG. 34 REVOLUTIONS MEDICAL CORPORATION FINANCIAL REVENUES BY YEAR

FIG. 35 SWOT ANALYSIS OF REVOLUTIONS MEDICAL, INC.

FIG. 36 RETRACTABLE TECHNOLOGIES, INC. FINANCIAL REVENUES BY YEAR (2011-2014)

FIG. 37 RETRACTABLE TECHNOLOGIES, INC. FINANCIAL REVENUE BY GEOGRAPHY (2014)

FIG. 38 SWOT ANALYSIS OF RETRACTABLE TECHNOLOGIES, INC